nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—ABCB1—Naltrexone—alcohol dependence	0.183	0.296	CbGbCtD
Toremifene—CYP1A2—Citalopram—alcohol dependence	0.138	0.225	CbGbCtD
Toremifene—ABCB1—Citalopram—alcohol dependence	0.121	0.196	CbGbCtD
Toremifene—CYP3A4—Disulfiram—alcohol dependence	0.102	0.165	CbGbCtD
Toremifene—CYP3A4—Citalopram—alcohol dependence	0.0725	0.118	CbGbCtD
Toremifene—Stiffness—Naltrexone—alcohol dependence	0.00735	0.032	CcSEcCtD
Toremifene—Appetite absent—Naltrexone—alcohol dependence	0.00562	0.0245	CcSEcCtD
Toremifene—CYP1A1—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00541	0.0414	CbGpPWpGaD
Toremifene—ABCB1—Abacavir transport and metabolism—ADH1A—alcohol dependence	0.00522	0.0399	CbGpPWpGaD
Toremifene—Deep vein thrombosis—Naltrexone—alcohol dependence	0.0046	0.02	CcSEcCtD
Toremifene—CYP1A1—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00448	0.0343	CbGpPWpGaD
Toremifene—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00416	0.0318	CbGpPWpGaD
Toremifene—CYP1A1—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00381	0.0292	CbGpPWpGaD
Toremifene—Disorder sight—Citalopram—alcohol dependence	0.00372	0.0162	CcSEcCtD
Toremifene—CYP1A2—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00345	0.0264	CbGpPWpGaD
Toremifene—Rigors—Naltrexone—alcohol dependence	0.00342	0.0149	CcSEcCtD
Toremifene—Neuropathy peripheral—Disulfiram—alcohol dependence	0.00329	0.0143	CcSEcCtD
Toremifene—Jaundice—Disulfiram—alcohol dependence	0.00327	0.0142	CcSEcCtD
Toremifene—CYP1A1—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00324	0.0248	CbGpPWpGaD
Toremifene—Musculoskeletal stiffness—Naltrexone—alcohol dependence	0.00312	0.0136	CcSEcCtD
Toremifene—Pulmonary embolism—Acamprosate—alcohol dependence	0.00295	0.0129	CcSEcCtD
Toremifene—Deep vein thrombosis—Citalopram—alcohol dependence	0.00291	0.0127	CcSEcCtD
Toremifene—Polyp—Citalopram—alcohol dependence	0.00291	0.0127	CcSEcCtD
Toremifene—Vaginal discharge—Citalopram—alcohol dependence	0.00291	0.0127	CcSEcCtD
Toremifene—CYP1A2—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00286	0.0219	CbGpPWpGaD
Toremifene—CYP1A1—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00285	0.0218	CbGpPWpGaD
Toremifene—CYP1A1—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00284	0.0218	CbGpPWpGaD
Toremifene—Pulmonary embolism—Naltrexone—alcohol dependence	0.0028	0.0122	CcSEcCtD
Toremifene—Embolism—Citalopram—alcohol dependence	0.00276	0.012	CcSEcCtD
Toremifene—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00266	0.0204	CbGpPWpGaD
Toremifene—Cyst—Citalopram—alcohol dependence	0.00265	0.0115	CcSEcCtD
Toremifene—Abnormal vision—Acamprosate—alcohol dependence	0.00258	0.0112	CcSEcCtD
Toremifene—Thrombosis—Citalopram—alcohol dependence	0.0025	0.0109	CcSEcCtD
Toremifene—Thrombophlebitis—Acamprosate—alcohol dependence	0.00248	0.0108	CcSEcCtD
Toremifene—CYP1A2—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00243	0.0186	CbGpPWpGaD
Toremifene—Vaginal haemorrhage—Citalopram—alcohol dependence	0.00239	0.0104	CcSEcCtD
Toremifene—Glaucoma—Citalopram—alcohol dependence	0.00235	0.0102	CcSEcCtD
Toremifene—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00221	0.0169	CbGpPWpGaD
Toremifene—Arthritis—Acamprosate—alcohol dependence	0.00221	0.0096	CcSEcCtD
Toremifene—Cardiac failure—Acamprosate—alcohol dependence	0.0022	0.00956	CcSEcCtD
Toremifene—Rigors—Citalopram—alcohol dependence	0.00217	0.00944	CcSEcCtD
Toremifene—Hot flush—Naltrexone—alcohol dependence	0.00217	0.00944	CcSEcCtD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—alcohol dependence	0.00216	0.0165	CbGpPWpGaD
Toremifene—Menopausal symptoms—Naltrexone—alcohol dependence	0.00215	0.00936	CcSEcCtD
Toremifene—Diplopia—Acamprosate—alcohol dependence	0.00214	0.00933	CcSEcCtD
Toremifene—Arthritis—Naltrexone—alcohol dependence	0.00209	0.00909	CcSEcCtD
Toremifene—Lethargy—Naltrexone—alcohol dependence	0.00207	0.00901	CcSEcCtD
Toremifene—CYP1A2—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00207	0.0158	CbGpPWpGaD
Toremifene—CYP1A1—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.002	0.0153	CbGpPWpGaD
Toremifene—Liver function test abnormal—Acamprosate—alcohol dependence	0.00198	0.00862	CcSEcCtD
Toremifene—Musculoskeletal stiffness—Citalopram—alcohol dependence	0.00197	0.00859	CcSEcCtD
Toremifene—Skin discolouration—Citalopram—alcohol dependence	0.00196	0.00853	CcSEcCtD
Toremifene—Breast disorder—Acamprosate—alcohol dependence	0.00194	0.00843	CcSEcCtD
Toremifene—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00188	0.0144	CbGpPWpGaD
Toremifene—Cataract—Citalopram—alcohol dependence	0.00186	0.0081	CcSEcCtD
Toremifene—Fatigue—Disulfiram—alcohol dependence	0.00184	0.00803	CcSEcCtD
Toremifene—Pain—Disulfiram—alcohol dependence	0.00183	0.00796	CcSEcCtD
Toremifene—CYP1A2—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00182	0.0139	CbGpPWpGaD
Toremifene—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00181	0.0139	CbGpPWpGaD
Toremifene—Angina pectoris—Acamprosate—alcohol dependence	0.00181	0.00786	CcSEcCtD
Toremifene—Coordination abnormal—Citalopram—alcohol dependence	0.0018	0.00785	CcSEcCtD
Toremifene—Loperamide—POMC—alcohol dependence	0.00178	0.162	CrCbGaD
Toremifene—Pulmonary embolism—Citalopram—alcohol dependence	0.00177	0.00771	CcSEcCtD
Toremifene—CYP1A2—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00173	0.0132	CbGpPWpGaD
Toremifene—Angina pectoris—Naltrexone—alcohol dependence	0.00171	0.00744	CcSEcCtD
Toremifene—Weight increased—Acamprosate—alcohol dependence	0.00169	0.00734	CcSEcCtD
Toremifene—Dry eye—Citalopram—alcohol dependence	0.00164	0.00712	CcSEcCtD
Toremifene—Acute coronary syndrome—Acamprosate—alcohol dependence	0.00163	0.00709	CcSEcCtD
Toremifene—Myocardial infarction—Acamprosate—alcohol dependence	0.00162	0.00705	CcSEcCtD
Toremifene—CYP1A1—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.0016	0.0123	CbGpPWpGaD
Toremifene—Weight increased—Naltrexone—alcohol dependence	0.0016	0.00695	CcSEcCtD
Toremifene—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.0016	0.0122	CbGpPWpGaD
Toremifene—Sweating—Acamprosate—alcohol dependence	0.00158	0.0069	CcSEcCtD
Toremifene—Abnormal vision—Citalopram—alcohol dependence	0.00154	0.00672	CcSEcCtD
Toremifene—Acute coronary syndrome—Naltrexone—alcohol dependence	0.00154	0.00671	CcSEcCtD
Toremifene—Asthenia—Disulfiram—alcohol dependence	0.00154	0.00668	CcSEcCtD
Toremifene—Myocardial infarction—Naltrexone—alcohol dependence	0.00153	0.00667	CcSEcCtD
Toremifene—CYP1A1—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00152	0.0117	CbGpPWpGaD
Toremifene—Dextropropoxyphene—OPRK1—alcohol dependence	0.00149	0.136	CrCbGaD
Toremifene—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00148	0.00644	CcSEcCtD
Toremifene—ABCB1—Allograft Rejection—PECR—alcohol dependence	0.00148	0.0113	CbGpPWpGaD
Toremifene—Visual impairment—Acamprosate—alcohol dependence	0.00143	0.00622	CcSEcCtD
Toremifene—Loperamide—OPRK1—alcohol dependence	0.00142	0.13	CrCbGaD
Toremifene—Dizziness—Disulfiram—alcohol dependence	0.00142	0.00616	CcSEcCtD
Toremifene—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.0014	0.0107	CbGpPWpGaD
Toremifene—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.0014	0.0107	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—alcohol dependence	0.00138	0.0106	CbGpPWpGaD
Toremifene—Hot flush—Citalopram—alcohol dependence	0.00137	0.00598	CcSEcCtD
Toremifene—Menopausal symptoms—Citalopram—alcohol dependence	0.00136	0.00593	CcSEcCtD
Toremifene—Rash—Disulfiram—alcohol dependence	0.00135	0.00587	CcSEcCtD
Toremifene—Headache—Disulfiram—alcohol dependence	0.00134	0.00583	CcSEcCtD
Toremifene—CYP1A1—Xenobiotics—CYP2E1—alcohol dependence	0.00134	0.0103	CbGpPWpGaD
Toremifene—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00133	0.0102	CbGpPWpGaD
Toremifene—Chills—Acamprosate—alcohol dependence	0.00133	0.00579	CcSEcCtD
Toremifene—Arthritis—Citalopram—alcohol dependence	0.00132	0.00576	CcSEcCtD
Toremifene—Cardiac failure—Citalopram—alcohol dependence	0.00132	0.00573	CcSEcCtD
Toremifene—Lethargy—Citalopram—alcohol dependence	0.00131	0.00571	CcSEcCtD
Toremifene—Eye disorder—Naltrexone—alcohol dependence	0.00131	0.00571	CcSEcCtD
Toremifene—Alopecia—Acamprosate—alcohol dependence	0.00131	0.00571	CcSEcCtD
Toremifene—Mental disorder—Acamprosate—alcohol dependence	0.0013	0.00566	CcSEcCtD
Toremifene—Malnutrition—Acamprosate—alcohol dependence	0.00129	0.00562	CcSEcCtD
Toremifene—CYP1A1—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00129	0.00986	CbGpPWpGaD
Toremifene—Diplopia—Citalopram—alcohol dependence	0.00129	0.0056	CcSEcCtD
Toremifene—CYP1A2—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00128	0.00978	CbGpPWpGaD
Toremifene—Angiopathy—Naltrexone—alcohol dependence	0.00127	0.00554	CcSEcCtD
Toremifene—Affect lability—Citalopram—alcohol dependence	0.00127	0.00551	CcSEcCtD
Toremifene—Mediastinal disorder—Naltrexone—alcohol dependence	0.00127	0.00551	CcSEcCtD
Toremifene—CYP1A1—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00126	0.00967	CbGpPWpGaD
Toremifene—Chills—Naltrexone—alcohol dependence	0.00126	0.00548	CcSEcCtD
Toremifene—Back pain—Acamprosate—alcohol dependence	0.00125	0.00544	CcSEcCtD
Toremifene—Alopecia—Naltrexone—alcohol dependence	0.00124	0.0054	CcSEcCtD
Toremifene—Mental disorder—Naltrexone—alcohol dependence	0.00123	0.00535	CcSEcCtD
Toremifene—Malnutrition—Naltrexone—alcohol dependence	0.00122	0.00532	CcSEcCtD
Toremifene—Mood swings—Citalopram—alcohol dependence	0.00122	0.0053	CcSEcCtD
Toremifene—Tremor—Acamprosate—alcohol dependence	0.00121	0.00527	CcSEcCtD
Toremifene—Ataxia—Citalopram—alcohol dependence	0.00121	0.00526	CcSEcCtD
Toremifene—Liver function test abnormal—Citalopram—alcohol dependence	0.00119	0.00517	CcSEcCtD
Toremifene—Back pain—Naltrexone—alcohol dependence	0.00118	0.00514	CcSEcCtD
Toremifene—Breast disorder—Citalopram—alcohol dependence	0.00116	0.00506	CcSEcCtD
Toremifene—Vertigo—Acamprosate—alcohol dependence	0.00116	0.00505	CcSEcCtD
Toremifene—Leukopenia—Acamprosate—alcohol dependence	0.00116	0.00503	CcSEcCtD
Toremifene—Vision blurred—Naltrexone—alcohol dependence	0.00115	0.00501	CcSEcCtD
Toremifene—Tremor—Naltrexone—alcohol dependence	0.00114	0.00498	CcSEcCtD
Toremifene—Chest pain—Acamprosate—alcohol dependence	0.0011	0.00479	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00109	0.00475	CcSEcCtD
Toremifene—Angina pectoris—Citalopram—alcohol dependence	0.00108	0.00471	CcSEcCtD
Toremifene—CYP1A1—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00107	0.00822	CbGpPWpGaD
Toremifene—Dextropropoxyphene—OPRD1—alcohol dependence	0.00105	0.0959	CrCbGaD
Toremifene—Chest pain—Naltrexone—alcohol dependence	0.00104	0.00453	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00103	0.0045	CcSEcCtD
Toremifene—Thrombocytopenia—Acamprosate—alcohol dependence	0.00103	0.00449	CcSEcCtD
Toremifene—Skin disorder—Acamprosate—alcohol dependence	0.00102	0.00446	CcSEcCtD
Toremifene—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00102	0.00782	CbGpPWpGaD
Toremifene—Hyperhidrosis—Acamprosate—alcohol dependence	0.00102	0.00443	CcSEcCtD
Toremifene—CYP1A1—Tryptophan metabolism—MAOB—alcohol dependence	0.00101	0.00775	CbGpPWpGaD
Toremifene—Weight increased—Citalopram—alcohol dependence	0.00101	0.0044	CcSEcCtD
Toremifene—Anorexia—Acamprosate—alcohol dependence	0.001	0.00437	CcSEcCtD
Toremifene—Loperamide—OPRD1—alcohol dependence	0.001	0.0914	CrCbGaD
Toremifene—Oedema—Naltrexone—alcohol dependence	0.000997	0.00434	CcSEcCtD
Toremifene—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000986	0.00754	CbGpPWpGaD
Toremifene—Nervous system disorder—Naltrexone—alcohol dependence	0.000978	0.00426	CcSEcCtD
Toremifene—Acute coronary syndrome—Citalopram—alcohol dependence	0.000977	0.00425	CcSEcCtD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000972	0.00744	CbGpPWpGaD
Toremifene—Neuropathy peripheral—Citalopram—alcohol dependence	0.000971	0.00423	CcSEcCtD
Toremifene—Myocardial infarction—Citalopram—alcohol dependence	0.000971	0.00423	CcSEcCtD
Toremifene—Skin disorder—Naltrexone—alcohol dependence	0.000969	0.00422	CcSEcCtD
Toremifene—Jaundice—Citalopram—alcohol dependence	0.000966	0.0042	CcSEcCtD
Toremifene—Hyperhidrosis—Naltrexone—alcohol dependence	0.000964	0.0042	CcSEcCtD
Toremifene—Insomnia—Acamprosate—alcohol dependence	0.000953	0.00415	CcSEcCtD
Toremifene—Anorexia—Naltrexone—alcohol dependence	0.000951	0.00414	CcSEcCtD
Toremifene—Sweating—Citalopram—alcohol dependence	0.00095	0.00413	CcSEcCtD
Toremifene—Dyspnoea—Acamprosate—alcohol dependence	0.00094	0.00409	CcSEcCtD
Toremifene—Hepatobiliary disease—Citalopram—alcohol dependence	0.000937	0.00408	CcSEcCtD
Toremifene—Decreased appetite—Acamprosate—alcohol dependence	0.000916	0.00399	CcSEcCtD
Toremifene—CYP1A1—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000913	0.00699	CbGpPWpGaD
Toremifene—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00091	0.00396	CcSEcCtD
Toremifene—Insomnia—Naltrexone—alcohol dependence	0.000902	0.00393	CcSEcCtD
Toremifene—Constipation—Acamprosate—alcohol dependence	0.000901	0.00392	CcSEcCtD
Toremifene—Pain—Acamprosate—alcohol dependence	0.000901	0.00392	CcSEcCtD
Toremifene—Dyspnoea—Naltrexone—alcohol dependence	0.000889	0.00387	CcSEcCtD
Toremifene—Decreased appetite—Naltrexone—alcohol dependence	0.000867	0.00377	CcSEcCtD
Toremifene—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000861	0.00375	CcSEcCtD
Toremifene—CYP1A1—Tryptophan metabolism—ALDH2—alcohol dependence	0.000861	0.00659	CbGpPWpGaD
Toremifene—Fatigue—Naltrexone—alcohol dependence	0.00086	0.00374	CcSEcCtD
Toremifene—Visual impairment—Citalopram—alcohol dependence	0.000857	0.00373	CcSEcCtD
Toremifene—CYP1A2—Xenobiotics—CYP2E1—alcohol dependence	0.000854	0.00654	CbGpPWpGaD
Toremifene—Pain—Naltrexone—alcohol dependence	0.000853	0.00371	CcSEcCtD
Toremifene—Constipation—Naltrexone—alcohol dependence	0.000853	0.00371	CcSEcCtD
Toremifene—Eye disorder—Citalopram—alcohol dependence	0.000831	0.00362	CcSEcCtD
Toremifene—CYP1A2—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000821	0.00629	CbGpPWpGaD
Toremifene—CYP1A1—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000819	0.00627	CbGpPWpGaD
Toremifene—CYP1A2—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000817	0.00625	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—ADH6—alcohol dependence	0.00081	0.0062	CbGpPWpGaD
Toremifene—Angiopathy—Citalopram—alcohol dependence	0.000807	0.00351	CcSEcCtD
Toremifene—Dextropropoxyphene—OPRM1—alcohol dependence	0.000805	0.0734	CrCbGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000805	0.00616	CbGpPWpGaD
Toremifene—Mediastinal disorder—Citalopram—alcohol dependence	0.000802	0.00349	CcSEcCtD
Toremifene—CYP1A1—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000801	0.00613	CbGpPWpGaD
Toremifene—Chills—Citalopram—alcohol dependence	0.000798	0.00347	CcSEcCtD
Toremifene—CYP1A1—Oxidative Stress—MAOA—alcohol dependence	0.000797	0.0061	CbGpPWpGaD
Toremifene—Arrhythmia—Citalopram—alcohol dependence	0.000795	0.00346	CcSEcCtD
Toremifene—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000788	0.00603	CbGpPWpGaD
Toremifene—Alopecia—Citalopram—alcohol dependence	0.000786	0.00342	CcSEcCtD
Toremifene—Mental disorder—Citalopram—alcohol dependence	0.000779	0.00339	CcSEcCtD
Toremifene—Malnutrition—Citalopram—alcohol dependence	0.000774	0.00337	CcSEcCtD
Toremifene—Loperamide—OPRM1—alcohol dependence	0.000767	0.0699	CrCbGaD
Toremifene—Asthenia—Acamprosate—alcohol dependence	0.000756	0.00329	CcSEcCtD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00075	0.00574	CbGpPWpGaD
Toremifene—Back pain—Citalopram—alcohol dependence	0.000749	0.00326	CcSEcCtD
Toremifene—Pruritus—Acamprosate—alcohol dependence	0.000746	0.00325	CcSEcCtD
Toremifene—Vision blurred—Citalopram—alcohol dependence	0.00073	0.00318	CcSEcCtD
Toremifene—Tremor—Citalopram—alcohol dependence	0.000725	0.00316	CcSEcCtD
Toremifene—Asthenia—Naltrexone—alcohol dependence	0.000716	0.00311	CcSEcCtD
Toremifene—Pruritus—Naltrexone—alcohol dependence	0.000706	0.00307	CcSEcCtD
Toremifene—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.0007	0.00536	CbGpPWpGaD
Toremifene—Dizziness—Acamprosate—alcohol dependence	0.000697	0.00303	CcSEcCtD
Toremifene—Vertigo—Citalopram—alcohol dependence	0.000696	0.00303	CcSEcCtD
Toremifene—Leukopenia—Citalopram—alcohol dependence	0.000693	0.00302	CcSEcCtD
Toremifene—CYP1A1—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000688	0.00527	CbGpPWpGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000685	0.00524	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—ADH1A—alcohol dependence	0.000671	0.00513	CbGpPWpGaD
Toremifene—Vomiting—Acamprosate—alcohol dependence	0.00067	0.00292	CcSEcCtD
Toremifene—Rash—Acamprosate—alcohol dependence	0.000665	0.00289	CcSEcCtD
Toremifene—Dermatitis—Acamprosate—alcohol dependence	0.000664	0.00289	CcSEcCtD
Toremifene—CYP1A1—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000663	0.00508	CbGpPWpGaD
Toremifene—Headache—Acamprosate—alcohol dependence	0.00066	0.00287	CcSEcCtD
Toremifene—Dizziness—Naltrexone—alcohol dependence	0.00066	0.00287	CcSEcCtD
Toremifene—ESR1—brainstem—alcohol dependence	0.000659	0.0531	CbGeAlD
Toremifene—Chest pain—Citalopram—alcohol dependence	0.000659	0.00287	CcSEcCtD
Toremifene—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000659	0.00505	CbGpPWpGaD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000655	0.00285	CcSEcCtD
Toremifene—CYP1A2—Tryptophan metabolism—MAOB—alcohol dependence	0.000645	0.00494	CbGpPWpGaD
Toremifene—ESR1—forebrain—alcohol dependence	0.000636	0.0512	CbGeAlD
Toremifene—Vomiting—Naltrexone—alcohol dependence	0.000634	0.00276	CcSEcCtD
Toremifene—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000634	0.00485	CbGpPWpGaD
Toremifene—Oedema—Citalopram—alcohol dependence	0.000632	0.00275	CcSEcCtD
Toremifene—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000631	0.00483	CbGpPWpGaD
Toremifene—Rash—Naltrexone—alcohol dependence	0.000629	0.00274	CcSEcCtD
Toremifene—Clomifene—CYP2E1—alcohol dependence	0.000629	0.0573	CrCbGaD
Toremifene—Dermatitis—Naltrexone—alcohol dependence	0.000628	0.00273	CcSEcCtD
Toremifene—Nausea—Acamprosate—alcohol dependence	0.000626	0.00272	CcSEcCtD
Toremifene—Headache—Naltrexone—alcohol dependence	0.000625	0.00272	CcSEcCtD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000621	0.00476	CbGpPWpGaD
Toremifene—Nervous system disorder—Citalopram—alcohol dependence	0.00062	0.0027	CcSEcCtD
Toremifene—Thrombocytopenia—Citalopram—alcohol dependence	0.000619	0.00269	CcSEcCtD
Toremifene—Skin disorder—Citalopram—alcohol dependence	0.000614	0.00267	CcSEcCtD
Toremifene—Hyperhidrosis—Citalopram—alcohol dependence	0.000611	0.00266	CcSEcCtD
Toremifene—Anorexia—Citalopram—alcohol dependence	0.000602	0.00262	CcSEcCtD
Toremifene—Nausea—Naltrexone—alcohol dependence	0.000592	0.00258	CcSEcCtD
Toremifene—CYP1A1—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000591	0.00452	CbGpPWpGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000582	0.00446	CbGpPWpGaD
Toremifene—Insomnia—Citalopram—alcohol dependence	0.000572	0.00249	CcSEcCtD
Toremifene—CYP1A1—Biological oxidations—ADH4—alcohol dependence	0.00057	0.00437	CbGpPWpGaD
Toremifene—CYP1A1—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000564	0.00432	CbGpPWpGaD
Toremifene—Dyspnoea—Citalopram—alcohol dependence	0.000563	0.00245	CcSEcCtD
Toremifene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000559	0.00428	CbGpPWpGaD
Toremifene—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000556	0.00426	CbGpPWpGaD
Toremifene—Decreased appetite—Citalopram—alcohol dependence	0.000549	0.00239	CcSEcCtD
Toremifene—CYP1A1—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000549	0.0042	CbGpPWpGaD
Toremifene—CYP1A2—Tryptophan metabolism—ALDH2—alcohol dependence	0.000549	0.0042	CbGpPWpGaD
Toremifene—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000546	0.00237	CcSEcCtD
Toremifene—Fatigue—Citalopram—alcohol dependence	0.000545	0.00237	CcSEcCtD
Toremifene—Constipation—Citalopram—alcohol dependence	0.00054	0.00235	CcSEcCtD
Toremifene—Pain—Citalopram—alcohol dependence	0.00054	0.00235	CcSEcCtD
Toremifene—ESR1—cardiovascular system—alcohol dependence	0.000538	0.0433	CbGeAlD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000528	0.00404	CbGpPWpGaD
Toremifene—CYP1A2—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000522	0.004	CbGpPWpGaD
Toremifene—Benzphetamine—SLC6A3—alcohol dependence	0.00052	0.0474	CrCbGaD
Toremifene—CYP1A2—Biological oxidations—ADH6—alcohol dependence	0.000516	0.00395	CbGpPWpGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00051	0.00391	CbGpPWpGaD
Toremifene—CYP1A2—Phase II conjugation—GGT2—alcohol dependence	0.000507	0.00388	CbGpPWpGaD
Toremifene—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000498	0.00381	CbGpPWpGaD
Toremifene—ESR1—gonad—alcohol dependence	0.000488	0.0393	CbGeAlD
Toremifene—CYP1A1—Biological oxidations—ADH7—alcohol dependence	0.000485	0.00371	CbGpPWpGaD
Toremifene—Diphenhydramine—CHRM2—alcohol dependence	0.000479	0.0436	CrCbGaD
Toremifene—CYP1A1—Biological oxidations—GGT2—alcohol dependence	0.000465	0.00356	CbGpPWpGaD
Toremifene—Asthenia—Citalopram—alcohol dependence	0.000453	0.00197	CcSEcCtD
Toremifene—Orphenadrine—CHRM2—alcohol dependence	0.000453	0.0413	CrCbGaD
Toremifene—CYP1A1—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000451	0.00345	CbGpPWpGaD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000449	0.00344	CbGpPWpGaD
Toremifene—Pruritus—Citalopram—alcohol dependence	0.000447	0.00195	CcSEcCtD
Toremifene—ESR1—digestive system—alcohol dependence	0.000447	0.036	CbGeAlD
Toremifene—CYP1A2—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000439	0.00336	CbGpPWpGaD
Toremifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000431	0.0033	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—ADH1A—alcohol dependence	0.000428	0.00327	CbGpPWpGaD
Toremifene—ESR1—blood—alcohol dependence	0.000425	0.0343	CbGeAlD
Toremifene—CYP1A1—Biological oxidations—ADH1B—alcohol dependence	0.000425	0.00326	CbGpPWpGaD
Toremifene—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000423	0.00324	CbGpPWpGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000423	0.00324	CbGpPWpGaD
Toremifene—Dizziness—Citalopram—alcohol dependence	0.000418	0.00182	CcSEcCtD
Toremifene—Vomiting—Citalopram—alcohol dependence	0.000402	0.00175	CcSEcCtD
Toremifene—Rash—Citalopram—alcohol dependence	0.000398	0.00173	CcSEcCtD
Toremifene—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000398	0.00305	CbGpPWpGaD
Toremifene—Dermatitis—Citalopram—alcohol dependence	0.000398	0.00173	CcSEcCtD
Toremifene—ESR1—FOXM1 transcription factor network—EP300—alcohol dependence	0.000397	0.00304	CbGpPWpGaD
Toremifene—Headache—Citalopram—alcohol dependence	0.000396	0.00172	CcSEcCtD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000394	0.00302	CbGpPWpGaD
Toremifene—ESR1—FOXA1 transcription factor network—EP300—alcohol dependence	0.000382	0.00293	CbGpPWpGaD
Toremifene—CYP1A2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000377	0.00288	CbGpPWpGaD
Toremifene—Nausea—Citalopram—alcohol dependence	0.000375	0.00163	CcSEcCtD
Toremifene—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000371	0.00284	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000369	0.00282	CbGpPWpGaD
Toremifene—ESR1—endocrine gland—alcohol dependence	0.000369	0.0297	CbGeAlD
Toremifene—CYP1A2—Biological oxidations—ADH4—alcohol dependence	0.000364	0.00278	CbGpPWpGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00036	0.00275	CbGpPWpGaD
Toremifene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000355	0.00271	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—MAOB—alcohol dependence	0.000352	0.0027	CbGpPWpGaD
Toremifene—ESR1—testis—alcohol dependence	0.000352	0.0283	CbGeAlD
Toremifene—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.00035	0.00268	CbGpPWpGaD
Toremifene—ESR1—nervous system—alcohol dependence	0.000345	0.0278	CbGeAlD
Toremifene—CYP1A2—digestive system—alcohol dependence	0.000344	0.0277	CbGeAlD
Toremifene—CYP1A1—digestive system—alcohol dependence	0.00034	0.0273	CbGeAlD
Toremifene—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000339	0.00259	CbGpPWpGaD
Toremifene—ESR1—liver—alcohol dependence	0.000333	0.0268	CbGeAlD
Toremifene—ESR1—central nervous system—alcohol dependence	0.000333	0.0268	CbGeAlD
Toremifene—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.00033	0.00253	CbGpPWpGaD
Toremifene—CYP1A2—blood—alcohol dependence	0.000328	0.0264	CbGeAlD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000326	0.0025	CbGpPWpGaD
Toremifene—ESR1—cerebellum—alcohol dependence	0.000325	0.0262	CbGeAlD
Toremifene—CYP1A1—blood—alcohol dependence	0.000324	0.026	CbGeAlD
Toremifene—CYP1A2—Biological oxidations—ADH7—alcohol dependence	0.000309	0.00237	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—EP300—alcohol dependence	0.000302	0.00231	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—ALDH2—alcohol dependence	0.0003	0.00229	CbGpPWpGaD
Toremifene—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000298	0.00228	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—GGT2—alcohol dependence	0.000296	0.00227	CbGpPWpGaD
Toremifene—Tamoxifen—CYP2E1—alcohol dependence	0.000291	0.0265	CrCbGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000288	0.0022	CbGpPWpGaD
Toremifene—CYP1A2—endocrine gland—alcohol dependence	0.000284	0.0229	CbGeAlD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—EP300—alcohol dependence	0.000283	0.00217	CbGpPWpGaD
Toremifene—Orphenadrine—CYP2E1—alcohol dependence	0.000282	0.0257	CrCbGaD
Toremifene—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000281	0.00215	CbGpPWpGaD
Toremifene—CYP1A1—endocrine gland—alcohol dependence	0.000281	0.0226	CbGeAlD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000278	0.00212	CbGpPWpGaD
Toremifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000274	0.0021	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—ADH1B—alcohol dependence	0.000271	0.00208	CbGpPWpGaD
Toremifene—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.00027	0.00207	CbGpPWpGaD
Toremifene—ESR1—brain—alcohol dependence	0.000264	0.0213	CbGeAlD
Toremifene—ESR1—AP-1 transcription factor network—EP300—alcohol dependence	0.000264	0.00202	CbGpPWpGaD
Toremifene—CYP1A1—nervous system—alcohol dependence	0.000263	0.0211	CbGeAlD
Toremifene—CYP1A2—liver—alcohol dependence	0.000256	0.0207	CbGeAlD
Toremifene—CYP1A1—liver—alcohol dependence	0.000253	0.0204	CbGeAlD
Toremifene—CYP1A1—central nervous system—alcohol dependence	0.000253	0.0204	CbGeAlD
Toremifene—ABCB1—forebrain—alcohol dependence	0.000251	0.0202	CbGeAlD
Toremifene—ESR1—Gene Expression—CCAR1—alcohol dependence	0.00025	0.00191	CbGpPWpGaD
Toremifene—CYP3A4—digestive system—alcohol dependence	0.000249	0.0201	CbGeAlD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000244	0.00187	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000244	0.00187	CbGpPWpGaD
Toremifene—CYP1A1—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000242	0.00185	CbGpPWpGaD
Toremifene—CYP1A2—Phase II conjugation—GGT1—alcohol dependence	0.00024	0.00183	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—CYP2E1—alcohol dependence	0.00024	0.00183	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000239	0.00183	CbGpPWpGaD
Toremifene—CYP3A4—blood—alcohol dependence	0.000237	0.0191	CbGeAlD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000237	0.00181	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000236	0.00181	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—alcohol dependence	0.000235	0.0018	CbGpPWpGaD
Toremifene—ABCB1—adrenal cortex—alcohol dependence	0.000233	0.0187	CbGeAlD
Toremifene—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000229	0.00175	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—MAOB—alcohol dependence	0.000225	0.00172	CbGpPWpGaD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000222	0.0017	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—GGT1—alcohol dependence	0.00022	0.00168	CbGpPWpGaD
Toremifene—ABCB1—cardiovascular system—alcohol dependence	0.000213	0.0171	CbGeAlD
Toremifene—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000209	0.0016	CbGpPWpGaD
Toremifene—ABCB1—pancreas—alcohol dependence	0.000207	0.0166	CbGeAlD
Toremifene—CYP3A4—endocrine gland—alcohol dependence	0.000206	0.0166	CbGeAlD
Toremifene—CYP1A1—brain—alcohol dependence	0.000201	0.0162	CbGeAlD
Toremifene—CYP1A1—Biological oxidations—MAOA—alcohol dependence	0.000197	0.00151	CbGpPWpGaD
Toremifene—ABCB1—gonad—alcohol dependence	0.000193	0.0155	CbGeAlD
Toremifene—CYP3A4—nervous system—alcohol dependence	0.000193	0.0155	CbGeAlD
Toremifene—CYP1A2—Biological oxidations—ALDH2—alcohol dependence	0.000191	0.00146	CbGpPWpGaD
Toremifene—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.00019	0.00145	CbGpPWpGaD
Toremifene—CYP3A4—liver—alcohol dependence	0.000186	0.0149	CbGeAlD
Toremifene—CYP3A4—central nervous system—alcohol dependence	0.000186	0.0149	CbGeAlD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000183	0.0014	CbGpPWpGaD
Toremifene—ABCB1—digestive system—alcohol dependence	0.000176	0.0142	CbGeAlD
Toremifene—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000173	0.00133	CbGpPWpGaD
Toremifene—ABCB1—blood—alcohol dependence	0.000168	0.0135	CbGeAlD
Toremifene—ABCB1—midbrain—alcohol dependence	0.000166	0.0134	CbGeAlD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000156	0.00119	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000156	0.00119	CbGpPWpGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000154	0.00118	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—CYP2E1—alcohol dependence	0.000153	0.00117	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000151	0.00115	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000147	0.00113	CbGpPWpGaD
Toremifene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000147	0.00112	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—EP300—alcohol dependence	0.000146	0.00112	CbGpPWpGaD
Toremifene—ABCB1—endocrine gland—alcohol dependence	0.000146	0.0117	CbGeAlD
Toremifene—ESR1—Integrated Breast Cancer Pathway—EP300—alcohol dependence	0.000143	0.00109	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000141	0.00108	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—GGT1—alcohol dependence	0.00014	0.00107	CbGpPWpGaD
Toremifene—ABCB1—testis—alcohol dependence	0.000139	0.0112	CbGeAlD
Toremifene—CYP1A1—Metabolism—ADH6—alcohol dependence	0.000138	0.00106	CbGpPWpGaD
Toremifene—ABCB1—nervous system—alcohol dependence	0.000136	0.011	CbGeAlD
Toremifene—ESR1—Signaling Pathways—OPRK1—alcohol dependence	0.000132	0.00101	CbGpPWpGaD
Toremifene—ABCB1—liver—alcohol dependence	0.000131	0.0106	CbGeAlD
Toremifene—ABCB1—central nervous system—alcohol dependence	0.000131	0.0106	CbGeAlD
Toremifene—ABCB1—cerebellum—alcohol dependence	0.000128	0.0103	CbGeAlD
Toremifene—CYP1A1—Biological oxidations—POMC—alcohol dependence	0.000128	0.000982	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—MAOA—alcohol dependence	0.000126	0.000962	CbGpPWpGaD
Toremifene—CYP1A1—PPARA activates gene expression—EP300—alcohol dependence	0.000122	0.000932	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.00012	0.000921	CbGpPWpGaD
Toremifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—alcohol dependence	0.000119	0.000912	CbGpPWpGaD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000119	0.00091	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000118	0.000904	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000118	0.000902	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000116	0.00089	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ADH1A—alcohol dependence	0.000115	0.000878	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ADH6—alcohol dependence	0.000111	0.000846	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000108	0.000828	CbGpPWpGaD
Toremifene—ABCB1—brain—alcohol dependence	0.000104	0.0084	CbGeAlD
Toremifene—CYP1A1—Metabolism—ADH4—alcohol dependence	9.75e-05	0.000747	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—MAOA—alcohol dependence	9.7e-05	0.000742	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ADH1A—alcohol dependence	9.16e-05	0.000701	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—OPRD1—alcohol dependence	8.9e-05	0.000681	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ADH6—alcohol dependence	8.83e-05	0.000676	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PDYN—alcohol dependence	8.53e-05	0.000653	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	8.45e-05	0.000646	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ADH7—alcohol dependence	8.29e-05	0.000635	CbGpPWpGaD
Toremifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—alcohol dependence	8.21e-05	0.000628	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—POMC—alcohol dependence	8.18e-05	0.000626	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GGT2—alcohol dependence	7.95e-05	0.000609	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—WASF2—alcohol dependence	7.93e-05	0.000607	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CRHR1—alcohol dependence	7.93e-05	0.000607	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ADH4—alcohol dependence	7.79e-05	0.000596	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—WASF1—alcohol dependence	7.61e-05	0.000582	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CHRM2—alcohol dependence	7.46e-05	0.000571	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ADH1A—alcohol dependence	7.31e-05	0.00056	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ADH1B—alcohol dependence	7.27e-05	0.000557	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—OPRM1—alcohol dependence	6.85e-05	0.000524	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ADH6—alcohol dependence	6.81e-05	0.000521	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	6.81e-05	0.000521	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ADH7—alcohol dependence	6.62e-05	0.000507	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GGT2—alcohol dependence	6.35e-05	0.000486	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—POMC—alcohol dependence	6.31e-05	0.000483	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NPY—alcohol dependence	6.3e-05	0.000482	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	6.25e-05	0.000479	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ADH4—alcohol dependence	6.22e-05	0.000476	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HTR1B—alcohol dependence	6.08e-05	0.000465	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CRH—alcohol dependence	6.08e-05	0.000465	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MAOB—alcohol dependence	6.03e-05	0.000461	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ADH1B—alcohol dependence	5.81e-05	0.000445	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ADH1A—alcohol dependence	5.65e-05	0.000432	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	5.63e-05	0.000431	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	5.38e-05	0.000412	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—DRD4—alcohol dependence	5.32e-05	0.000407	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ADH7—alcohol dependence	5.29e-05	0.000405	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ALDH2—alcohol dependence	5.12e-05	0.000392	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CNR1—alcohol dependence	5.08e-05	0.000388	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GGT2—alcohol dependence	5.07e-05	0.000388	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HTR7—alcohol dependence	4.95e-05	0.000379	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—DRD2—alcohol dependence	4.95e-05	0.000379	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.93e-05	0.000377	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MAOB—alcohol dependence	4.81e-05	0.000368	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ADH4—alcohol dependence	4.8e-05	0.000367	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ADH1B—alcohol dependence	4.64e-05	0.000355	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GOT2—alcohol dependence	4.36e-05	0.000333	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AVP—alcohol dependence	4.17e-05	0.000319	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP2E1—alcohol dependence	4.1e-05	0.000314	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALDH2—alcohol dependence	4.09e-05	0.000313	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ADH7—alcohol dependence	4.08e-05	0.000312	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GGT2—alcohol dependence	3.91e-05	0.0003	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MAOB—alcohol dependence	3.84e-05	0.000294	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GGT1—alcohol dependence	3.76e-05	0.000288	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GOT1—alcohol dependence	3.76e-05	0.000288	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ADH1B—alcohol dependence	3.58e-05	0.000274	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GOT2—alcohol dependence	3.48e-05	0.000266	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HTR2A—alcohol dependence	3.47e-05	0.000265	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MAOA—alcohol dependence	3.37e-05	0.000258	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP2E1—alcohol dependence	3.27e-05	0.00025	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3.27e-05	0.00025	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALDH2—alcohol dependence	3.27e-05	0.00025	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.14e-05	0.00024	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GOT1—alcohol dependence	3e-05	0.00023	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GGT1—alcohol dependence	3e-05	0.00023	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MAOB—alcohol dependence	2.97e-05	0.000227	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GOT2—alcohol dependence	2.78e-05	0.000213	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—POMC—alcohol dependence	2.77e-05	0.000212	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MAOA—alcohol dependence	2.69e-05	0.000206	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP2E1—alcohol dependence	2.61e-05	0.0002	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.52e-05	0.000193	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GGT1—alcohol dependence	2.4e-05	0.000184	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GOT1—alcohol dependence	2.4e-05	0.000184	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—POMC—alcohol dependence	2.19e-05	0.000168	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MAOA—alcohol dependence	2.15e-05	0.000164	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GOT2—alcohol dependence	2.14e-05	0.000164	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.08e-05	0.00016	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP2E1—alcohol dependence	2.02e-05	0.000154	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GGT1—alcohol dependence	1.85e-05	0.000142	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GOT1—alcohol dependence	1.85e-05	0.000142	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EP300—alcohol dependence	1.84e-05	0.000141	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—POMC—alcohol dependence	1.75e-05	0.000134	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MAOA—alcohol dependence	1.66e-05	0.000127	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—EP300—alcohol dependence	1.46e-05	0.000111	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—POMC—alcohol dependence	1.4e-05	0.000107	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—EP300—alcohol dependence	1.16e-05	8.9e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—POMC—alcohol dependence	1.08e-05	8.26e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—EP300—alcohol dependence	9.28e-06	7.1e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—EP300—alcohol dependence	7.16e-06	5.48e-05	CbGpPWpGaD
